 "Eris Lifesciences")
Eris Lifesciences was up 3% at Rs 817 on the BSE in early morning trade, trading higher for the fifth straight trading day.
The stock of pharmaceutical company outperformed the market by gaining 12% from Rs 732 on February 26, 2018, as compared to 1.3% decline in the S&P BSE Sensex. It is trading close to its highest level at Rs 831, touched on November 30, 2017 in intra-day trade. The stock made debut on bourses on June 26 last year.
The stock of pharmaceutical company outperformed the market by gaining 12% from Rs 732 on February 26, 2018, as compared to 1.3% decline in the S&P BSE Sensex. It is trading close to its highest level at Rs 831, touched on November 30, 2017 in intra-day trade. The stock made debut on bourses on June 26 last year.
Eris Lifesciences, engaged in the business of manufacturing and marketing branded formulations, had raised Rs 7.4 billion through
